Clinical Trials Logo

Filter by:
NCT ID: NCT06146023 Completed - Robotic Surgery Clinical Trials

Performance of Robotic Microsurgery Systems

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The goal of this preclinical trial is to learn about the benefits and limitations of novel robotic devices for microsurgery, based on different levels of microsurgical experience. The main questions it aims to answer are: Is robot-assisted microsurgery faster, better and more ergonomic than conventional microsurgery in a preclinical standardized setting? Participants will perform microvascular anastomoses on 1.0-mm-diameter artificial silicone vessels using a conventional manual approach versus a novel robot-assisted approach. Researchers will compare the performance of novices, advanced participants and experts to evaluate the role of microsurgical experience when learning the new technique.

NCT ID: NCT06121596 Completed - Breathing Exercises Clinical Trials

Relaxation Effects of Personalized Breathing Exercises for Healthy College Students

Start date: July 31, 2023
Phase: N/A
Study type: Interventional

Stress plays a major role in the etiology and pathogenesis of anxiety and depression. Relaxation therapies, such as breathing exercises, can reduce stress and increase relaxation. This study has two aims. First, it aims to personalize and optimize breathing protocols. Second, it aims to tailor breathing protocols to subgroups based on prediction models of expected efficacy. Three different breathing protocols, varying solely in their instructed breathing frequency with 40 percent (A), 60 percent (B), and 80 percent (C) of the interindividual spontaneous breathing frequency, are tested in a randomized, counterbalanced crossover trial. Other parameters, such as breathing quality (i.e., nasal and diaphragmatic), rhythm (i.e., prolonged exhalation without instructed pauses) and depth (i.e., increased depth due to slower breathing frequency) as well as contextual factors (e.g., posture, video-based instructions, type of pacer, etc.) are invariant between protocols. First, this study hypothesizes a difference in the relaxation response between breathing protocols A, B, and C. This study looks at the relaxation response from three different angles (1) self-report, (2) autonomic arousal, and (3) central nervous system arousal. Second, this study explores prediction models of expected efficacy based on the interindividual variance in characteristics (i.e., depressive, anxious and stress symptoms as well as expertise in relaxation therapies) and biomarkers (e.g., heart rate variability, peripheral temperature, skin conductance, etc.). Prediction models can tailor breathing protocols to subgroups to increase expected efficacy.

NCT ID: NCT06116344 Completed - Prostate Cancer Clinical Trials

Improving Prostate Lesion Classification and Development of a PI-RADS 3 Classifier

Start date: January 1, 2018
Phase:
Study type: Observational

The investigators propose an AI methodology combining machine learning, histological results and expert image interpretation for the development of a PI-RADS 3 classifier.

NCT ID: NCT06113796 Completed - Rectal Cancer Clinical Trials

Economic Analysis of Robotic Rectal Resection in German Health Care System

Start date: January 1, 2018
Phase:
Study type: Observational [Patient Registry]

Analysis of cost effectiveness of robotic rectal resection, either sphincter preserving or abdominoperineal extirpation, in the German diagnosis related groups (DRG) system.

NCT ID: NCT06111170 Completed - Clinical trials for Dermatochalasis of Eyelid

Effect of Compression Dressing After Upper Eyelid Blepharoplasty on Edema, Ecchymosis, Pain and Ocular Surface Irritation

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

Study to analyze whether there is a difference in postoperative outcome regarding edema, ecchymosis, pain, OSI and discomfort of the patients after blepharoplasty if a compression dressing is used or not.

NCT ID: NCT06095427 Completed - Healthy Clinical Trials

A Pharmacokinetic Similarity Study in Healthy Male Subjects to Evaluate Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of LY06006 Versus US-Prolia and EU-Prolia by Single-dose Subcutaneous Injection

Start date: March 9, 2021
Phase: Phase 1
Study type: Interventional

This trial is a randomized, double-blind, three-arm, parallel-group, pharmacokinetic study. The purpose of this study is to demonstrate pharmacokinetic (PK) similarity and to compare safety, immunogenicity and pharmacodynamics (PD) between the test product L06006 and the reference products US-Prolia and EU-Prolia in healthy male subjects. A total of 300 healthy male subjects aged 28 to 65 years (both inclusive) will be randomized 1:1:1 to receive a single subcutaneous (s.c.) injection of either LY06006 or US-Prolia or EU-Prolia on Day 1 and then be followed for 36 weeks.

NCT ID: NCT06075277 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test How BI 1810631 is Taken up in the Body When Taken With or Without Food

Start date: October 19, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the relative bioavailability of a single dose of BI 1810631 intended commercial formulation (iCF) under fed (Test treatment, T) and fasted (Reference treatment, R) conditions.

NCT ID: NCT06074874 Completed - Colitis Clinical Trials

Intestinal Biomarker Analysis After ECP for ICI Colitis

IBA_ECP
Start date: July 1, 2023
Phase:
Study type: Observational

It was previously shown that ICI-colitis can be treated with extracorporeal photophoresis. Therefore this retrospective analysis is launched to study the chnages of immune cells in the peripheral blood and intestinal tract in an ICI colitis patient cohort. The analysis will include the evaluation of intestinal and peripheral blood biomarkers in patients with ICI colitis receiving ECP as a treatment.

NCT ID: NCT06072209 Completed - Depression Moderate Clinical Trials

Long-term Effects ReSet Your Mind - Mechanisms

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

See: ClinicalTrials.gov ID: NCT05402150 Relevant for this Paper: This investigation aims to evaluate the stability of the effectiveness of different two-week online interventions in a four months follow-up regarding reward sensitivity, anhedonia and depression. The authors will further investigate factors influencing treatment success regarding reward sensitivity. The investigators assume that the more depressive expectations and stress improve during our online intervention, the more change in reward insensitivity is experienced at follow-up. In addition, it is hypothesized that the more people engaged in physical activities and social encounters during the two-week online intervention, the more change in reward insensitivity is experienced at follow-up.

NCT ID: NCT06070610 Completed - Healthy Clinical Trials

A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Nintedanib and Pirfenidone in the Blood

Start date: November 8, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this trial is to investigate the induction effect of multiple oral doses of BI 1015550 on the pharmacokinetics of nintedanib or pirfenidone.